Final 24 hours to access leading, independent market research on digital brain health & neurotechnology at discounted price

By SharpBrains | March 30, 2016

“The future is already here – it’s just not even­ly dis­trib­uted” — writer and futur­ist William Gib­son If you work at, com­pete with, or learn from, any of the com­pa­nies below, you may want to know what they are up to and why, via Sharp­Brains’ objec­tive and inde­pen­dent mar­ket reports. Which are avail­able at dis­count­ed price…

Read More

Can better cognitive testing platforms accelerate pharma’s Alzheimer’s research and development efforts?

By SharpBrains | May 4, 2015

. Alzheimer’s cure behind the boom in brain sci­ence (Finan­cial Review): “Bio­gen is one of many mem­bers of big phar­ma seek­ing the block­buster drug which will inevitably be worth mul­ti­ple bil­lions of dol­lars. Big phar­ma in the US spends about $US5 bil­lion a year on Alzheimer’s research and devel­op­ment. Expo­nen­tial growth in the dis­ease over…

Read More

Brain Training and Cognitive Assessment Market Surpassed $1.3 Billion In 2013

By SharpBrains | January 23, 2014

Heads-up: We just announced a new intel­li­gence pack­age aimed at edu­ca­tion, health, gam­ing and tech­nol­o­gy exec­u­tives and inno­va­tors. “Many mar­ket reports pro­vide lit­tle val­ue for the mon­ey. This mar­ket report by Sharp­Brains is the pre­cise oppo­site. Its wealth of data and analy­sis pro­vides very valu­able strate­gic and busi­ness devel­op­ment guid­ance to orga­ni­za­tions at the frontier…

Read More

Got Brain? Investing in Our Most Precious Asset in 2013

By Alvaro Fernandez | December 18, 2012

Open a week­end New York Times or Wall Street Jour­nal and you’ll find a whole sec­tion with detailed infor­ma­tion and advice for indi­vid­u­als look­ing to invest wise­ly. What you will not find, how­ev­er, is com­pa­ra­ble infor­ma­tion and advice for invest­ing in your most impor­tant asset of all: your brain. Pre­cise­ly because it (usu­al­ly) does its…

Read More